CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RNA

AOC 1001 (del-desiran)

Phase 3
Avidity Biosciences, Inc. (RNA)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
RNAPhase 3

AOC 1001 (del-desiran) Phase 3 Est. Readout

AOC 1001 (del-desiran)
Aug 2026~
CT.gov
00%
Competitive Landscape

0 competitors in DM1

View Full Landscape
Drug Information

Target Indication

DM1

Clinical Trial

NCT06411288

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.